Dividend Investing Ideas Center
Critical Facts You Need to Know About Preferred Stocks
Have you ever wished for the safety of bonds, but the return potential...
Delaware Healthcare Fund
mutual fund
DLHCX
Payout Change
Suspended
Price as of:
$21.87
+0.02
+0.09%
primary theme
Health Care Sector Equity
share class
DLHCX (Mutual Fund)
Delaware Healthcare Fund
Payout Change
Suspended
Price as of:
$21.87
+0.02
+0.09%
primary theme
Health Care Sector Equity
share class
DLHCX (Mutual Fund)
Delaware Healthcare Fund
Payout Change
Suspended
Price as of:
$21.87
+0.02
+0.09%
primary theme
Health Care Sector Equity
share class
Name
As of 12/09/2024Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
Vitals
YTD Return
12.2%
1 yr return
17.9%
3 Yr Avg Return
6.6%
5 Yr Avg Return
6.2%
Net Assets
$776 M
Holdings in Top 10
47.8%
52 WEEK LOW AND HIGH
$21.9
N/A
N/A
Expenses
OPERATING FEES
Expense Ratio 2.00%
SALES FEES
Front Load N/A
Deferred Load 1.00%
TRADING FEES
Turnover 1.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$1,000
IRA
$250
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 12/09/2024Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
DLHCX - Profile
Distributions
- YTD Total Return 12.2%
- 3 Yr Annualized Total Return 6.6%
- 5 Yr Annualized Total Return 6.2%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio -0.55%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Annual
Fund Details
-
Legal NameDelaware Healthcare Fund
-
Fund Family NameDelaware Funds by Macquarie
-
Inception DateJan 28, 2010
-
Shares OutstandingN/A
-
Share ClassC
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerLiu-Er Chen
Fund Description
Under normal circumstances, the Fund will invest at least 80% of its assets, plus the amount of any borrowings for investment purposes, in the equity securities of healthcare companies, meaning companies that develop, produce, or distribute products or services related to the healthcare or medical industries and derive a substantial portion, that is, more than 50%, of their sales from products and services in the healthcare industry (80% policy). These products and services include, but are not limited to, pharmaceutical companies, biotechnology companies, medical device and supply companies, managed care companies, and healthcare information and service providers. The Fund invests in US and non-US companies across all market capitalizations. The Fund may invest up to 50% of its total assets in non-US companies. The Fund may also invest up to 25% of its total assets in companies located in emerging markets. The Fund is a nondiversified fund.
The Manager may permit its affiliate, Macquarie Investment Management Global Limited (MIMGL), to execute Fund security trades on behalf of the Manager. The Manager may also seek quantitative support from MIMGL.
The Fund’s 80% policy is nonfundamental and may be changed without shareholder approval. Fund shareholders would be given at least 60 days’ notice prior to any such change.
DLHCX - Performance
Return Ranking - Trailing
| Period | DLHCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 12.2% | -19.4% | 22.6% | 24.53% |
| 1 Yr | 17.9% | -7.9% | 34.9% | 35.22% |
| 3 Yr | 6.6%* | -25.3% | 12.3% | 5.26% |
| 5 Yr | 6.2%* | -8.3% | 12.9% | 61.74% |
| 10 Yr | 8.7%* | -0.2% | 12.7% | 23.42% |
* Annualized
Return Ranking - Calendar
| Period | DLHCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2023 | -2.6% | -12.6% | 19.0% | 83.65% |
| 2022 | -10.6% | -53.9% | 3.2% | 29.61% |
| 2021 | -1.6% | -39.6% | 24.2% | 61.18% |
| 2020 | 4.3% | -13.6% | 178.2% | 85.91% |
| 2019 | 20.4% | 3.8% | 63.8% | 55.64% |
Total Return Ranking - Trailing
| Period | DLHCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 12.2% | -19.4% | 22.6% | 24.53% |
| 1 Yr | 17.9% | -7.9% | 34.9% | 35.22% |
| 3 Yr | 6.6%* | -25.3% | 12.3% | 5.26% |
| 5 Yr | 6.2%* | -8.3% | 12.9% | 61.74% |
| 10 Yr | 8.7%* | -0.2% | 12.7% | 23.42% |
* Annualized
Total Return Ranking - Calendar
| Period | DLHCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2023 | 3.5% | -12.6% | 19.0% | 62.26% |
| 2022 | -2.1% | -53.9% | 3.7% | 11.18% |
| 2021 | 4.5% | -33.9% | 26.0% | 71.71% |
| 2020 | 10.3% | -0.7% | 180.6% | 93.96% |
| 2019 | 30.5% | 4.6% | 63.8% | 30.08% |
NAV & Total Return History
DLHCX - Holdings
Concentration Analysis
| DLHCX | Category Low | Category High | DLHCX % Rank | |
|---|---|---|---|---|
| Net Assets | 776 M | 6.66 M | 45.7 B | 53.46% |
| Number of Holdings | 107 | 25 | 430 | 29.56% |
| Net Assets in Top 10 | 400 M | 2.12 M | 23.9 B | 54.09% |
| Weighting of Top 10 | 47.84% | 18.4% | 78.1% | 42.14% |
Top 10 Holdings
- Eli Lilly Co 9.33%
- Regeneron Pharmaceuticals Inc 5.91%
- UnitedHealth Group Inc 5.32%
- Amgen Inc 4.63%
- Merck Co Inc 4.53%
- Pfizer Inc 3.97%
- Elevance Health Inc 3.92%
- Boston Scientific Corp 3.81%
- Chugai Pharmaceutical Co Ltd 3.35%
- AbbVie Inc 3.07%
Asset Allocation
| Weighting | Return Low | Return High | DLHCX % Rank | |
|---|---|---|---|---|
| Stocks | 93.48% | 89.92% | 106.13% | 87.42% |
| Cash | 6.52% | 0.00% | 33.01% | 15.72% |
| Preferred Stocks | 0.00% | 0.00% | 7.86% | 66.04% |
| Other | 0.00% | -22.99% | 23.24% | 66.04% |
| Convertible Bonds | 0.00% | 0.00% | 0.37% | 51.30% |
| Bonds | 0.00% | 0.00% | 12.39% | 64.15% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | DLHCX % Rank | |
|---|---|---|---|---|
| Healthcare | 99.04% | 59.26% | 100.00% | 71.43% |
| Communication Services | 0.69% | 0.00% | 9.11% | 2.60% |
| Financial Services | 0.20% | 0.00% | 1.60% | 14.94% |
| Basic Materials | 0.07% | 0.00% | 7.16% | 31.82% |
| Utilities | 0.00% | 0.00% | 0.00% | 47.40% |
| Technology | 0.00% | 0.00% | 22.69% | 51.30% |
| Real Estate | 0.00% | 0.00% | 5.89% | 50.00% |
| Industrials | 0.00% | 0.00% | 7.02% | 51.30% |
| Energy | 0.00% | 0.00% | 0.00% | 47.40% |
| Consumer Defense | 0.00% | 0.00% | 25.73% | 54.55% |
| Consumer Cyclical | 0.00% | 0.00% | 1.92% | 50.00% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | DLHCX % Rank | |
|---|---|---|---|---|
| US | 79.92% | 61.27% | 104.41% | 77.99% |
| Non US | 13.56% | 0.00% | 34.10% | 22.01% |
DLHCX - Expenses
Operational Fees
| DLHCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 2.00% | 0.08% | 4.48% | 17.61% |
| Management Fee | 0.83% | 0.03% | 1.25% | 73.58% |
| 12b-1 Fee | 1.00% | 0.00% | 1.00% | 87.01% |
| Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
| DLHCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | 3.50% | 5.75% | N/A |
| Deferred Load | 1.00% | 1.00% | 1.00% | 50.00% |
Trading Fees
| DLHCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 1.00% | 1.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| DLHCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | 1.00% | 0.00% | 238.00% | 3.70% |
DLHCX - Distributions
Dividend Yield Analysis
| DLHCX | Category Low | Category High | DLHCX % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.00% | 0.00% | 6.24% | 2.52% |
Dividend Distribution Analysis
| DLHCX | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Annual | Annual | Quarterly | Annual |
Net Income Ratio Analysis
| DLHCX | Category Low | Category High | DLHCX % Rank | |
|---|---|---|---|---|
| Net Income Ratio | -0.55% | -2.54% | 1.85% | 71.71% |
Capital Gain Distribution Analysis
| DLHCX | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Annually | Annually | Semi-Annually | Annually |
Distributions History
| Date | Amount | Type |
|---|---|---|
| Dec 03, 2024 | $0.137 | CapitalGainShortTerm |
| Dec 03, 2024 | $3.126 | CapitalGainLongTerm |
| Dec 04, 2023 | $0.011 | CapitalGainShortTerm |
| Dec 04, 2023 | $1.299 | CapitalGainLongTerm |
| Dec 02, 2022 | $2.274 | CapitalGainLongTerm |
| Dec 03, 2021 | $1.476 | OrdinaryDividend |
| Dec 04, 2020 | $1.496 | OrdinaryDividend |
| Dec 05, 2019 | $0.224 | CapitalGainShortTerm |
| Dec 05, 2019 | $1.791 | CapitalGainLongTerm |
| Dec 06, 2018 | $0.263 | CapitalGainLongTerm |
| Dec 06, 2018 | $0.006 | OrdinaryDividend |
| Dec 05, 2017 | $0.529 | OrdinaryDividend |
| Dec 05, 2016 | $1.216 | CapitalGainLongTerm |
| Dec 05, 2016 | $0.042 | OrdinaryDividend |
| Dec 04, 2015 | $0.020 | OrdinaryDividend |
| Dec 04, 2015 | $0.024 | CapitalGainShortTerm |
| Dec 04, 2015 | $1.319 | CapitalGainLongTerm |
| Dec 05, 2014 | $1.289 | CapitalGainShortTerm |
| Dec 05, 2014 | $0.783 | CapitalGainLongTerm |
| Dec 06, 2013 | $0.319 | CapitalGainShortTerm |
| Dec 06, 2013 | $0.101 | CapitalGainLongTerm |
| Dec 06, 2010 | $0.616 | CapitalGainShortTerm |
| Dec 06, 2010 | $0.035 | CapitalGainLongTerm |
DLHCX - Fund Manager Analysis
Managers
Liu-Er Chen
Start Date
Tenure
Tenure Rank
Sep 28, 2007
14.68
14.7%
Liu-Er Chen, CFA, Senior Vice President, Chief Investment Officer — Emerging Markets and Healthcare, is a Portfolio Manager in Delaware Investments Fund Advisers, a series of Macquarie Investment Management Business Trust. Mr. Chen heads the firm's global Emerging Markets team. Prior to joining Macquarie Investment Management (MIM) in September 2006 in his current position, Mr. Chen spent nearly 11 years at Evergreen Investment Management Company, where he most recently served as Managing Director and Senior Portfolio Manager. Mr. Chen began his career at Evergreen in 1995 as an analyst.
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.02 | 24.72 | 7.88 | 0.25 |
